Dr. Roger Torres, MD (he/him) is a Internist in New Berlin, WI with over 18 years of experience. What is your opinion of Dr. Roger Torres, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 18 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Roger Torres, MD has received over $23,615 which includes payments from the following companies:
$2,680.32 from AstraZeneca Pharmaceuticals LP
$2,237.09 from Boehringer Ingelheim Pharmaceuticals, Inc.
$1,573.97 from Novo Nordisk Inc
$1,469.40 from Janssen Pharmaceuticals, Inc
$1,406.30 from Pfizer Inc.
$1,289.29 from Amgen Inc.
$1,094.45 from GlaxoSmithKline, LLC.
$1,027.57 from Takeda Pharmaceuticals America, Inc.
$958.48 from Allergan Inc.
$947.07 from LILLY USA, LLC
$858.84 from Merck Sharp & Dohme Corporation
$857.73 from Astellas Pharma US Inc
$792.73 from Kowa Pharmaceuticals America, Inc.
$751.20 from sanofi-aventis U.S. LLC
$600.85 from Daiichi Sankyo Inc.
$454.72 from Takeda Pharmaceuticals U.S.A., Inc.
$400.08 from Novartis Pharmaceuticals Corporation
$298.42 from Ironwood Pharmaceuticals, Inc
$297.57 from E.R. Squibb & Sons, L.L.C.
$242.98 from Salix Pharmaceuticals, a division of Bausch Health US, LLC
Payments received by Dr. Roger Torres, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!